Neuronetics

Neuronetics, Inc. was founded in 2003 by a professional neural network team and an experienced management team. It is a commercial-stage medical device company. Neuronetics is committed to developing non-invasive therapies for psychiatric and neurological disorders using MRI-strength magnetic field pulses. The company designs, develops, and markets products aimed at improving the quality of life for patients with mental health conditions. Notably, Neuronetics is the first and only company to receive FDA approval for a non-systemic and non-invasive treatment for depression.